Search research articles
Contact Us
Filters
Showing results (181-190 of 204) with videos related to
Page
of 21
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 19, 2017
Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment
Isaac Zentner, Chawangwa Modongo, Nicola M Zetola, et al.
Applied and Environmental Microbiology
|
July 24, 2012
Mycobacterial shuttle vectors designed for high-level protein expression in infected macrophages
Jennifer L Eitson, Jennifer J Medeiros, Ashley R Hoover, et al.
The Journal of Antimicrobial Chemotherapy
|
August 5, 2022
Potency of the novel PolC DNA polymerase inhibitor CRS0540 in a disseminated Listeria monocytogenes intracellular hollow-fibre model
Swati Patel, Moti Chapagain, Clifford Mason, et al.
Antimicrobial Agents and Chemotherapy
|
January 16, 2025
Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis
Vanessa B Vogensen, Sanjay Singh, Christopher J Allende, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2019
Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis
Jan-Willem C Alffenaar, Tawanda Gumbo, Kelly E Dooley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
Devyani Deshpande, Jotam G Pasipanodya, Shashikant Srivastava, et al.
International Journal of Antimicrobial Agents
|
May 15, 2023
Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease
Sanjay Singh, Jann-Yuan Wang, Scott K Heysell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis
Devyani Deshpande, Jotam G Pasipanodya, Stellah G Mpagama, et al.
Antimicrobial Agents and Chemotherapy
|
October 27, 2020
Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis
Suresh Mallikaarjun, Moti L Chapagain, Tomohiro Sasaki, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2007
Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing
William W Hope, Nita L Seibel, Cindy L Schwartz, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 204) with videos related to
Sort By:
Page
of 21
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 19, 2017
Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment
Isaac Zentner, Chawangwa Modongo, Nicola M Zetola, et al.
Applied and Environmental Microbiology
|
July 24, 2012
Mycobacterial shuttle vectors designed for high-level protein expression in infected macrophages
Jennifer L Eitson, Jennifer J Medeiros, Ashley R Hoover, et al.
The Journal of Antimicrobial Chemotherapy
|
August 5, 2022
Potency of the novel PolC DNA polymerase inhibitor CRS0540 in a disseminated Listeria monocytogenes intracellular hollow-fibre model
Swati Patel, Moti Chapagain, Clifford Mason, et al.
Antimicrobial Agents and Chemotherapy
|
January 16, 2025
Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis
Vanessa B Vogensen, Sanjay Singh, Christopher J Allende, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2019
Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis
Jan-Willem C Alffenaar, Tawanda Gumbo, Kelly E Dooley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
Devyani Deshpande, Jotam G Pasipanodya, Shashikant Srivastava, et al.
International Journal of Antimicrobial Agents
|
May 15, 2023
Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease
Sanjay Singh, Jann-Yuan Wang, Scott K Heysell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis
Devyani Deshpande, Jotam G Pasipanodya, Stellah G Mpagama, et al.
Antimicrobial Agents and Chemotherapy
|
October 27, 2020
Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis
Suresh Mallikaarjun, Moti L Chapagain, Tomohiro Sasaki, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2007
Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing
William W Hope, Nita L Seibel, Cindy L Schwartz, et al.
Page
of 21